Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real-World” study

Levi S.;Bronstein Y.;Goldschmidt N.;Morabito F.;Ziv-Baran T.;Del Poeta G.;Bairey O.;Del Principe M. I.;Fineman R.;Mauro F. R.;Gutwein O.;Reda G.;Ruchlemer R.;Sportoletti P.;Laurenti L.;Shvidel L.;Coscia M.;Tadmor T.;Varettoni M.;Aviv A.;Murru R.;Braester A.;Chiarenza A.;Visentin A.;Pietrasanta D.;Loseto G.;Zucchetto A.;Bomben R.;Olivieri J.;Neri A.;Rossi D.;Gaidano G.;Trentin L.;Foa R.;Cuneo A.;Perry C.;Gattei V.;Gentile M.;Herishanu Y.

2023-01-01